Entries by BuzziDev

Global Cannabis Closes Private Placement

Vancouver, British Columbia, Canada, January 7, 2021 – Global Cannabis Applications Corp.(“GCAC” or the “Company”) (CSE: APP, FSE: 2FA), a leading developer of innovative data technologies for the medical cannabis industry, announces it has closed its non-brokered private placement (the “Private Placement”). Pursuant to the Private Placement, the Company has issued 8,400,000 units at a price of […]

GCAC Signs Definitive Reseller Agreement for Efixii into $233 Million Israeli Medical Cannabis Market

Vancouver, British Columbia, Canada, January 4, 2021 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis data platform, today announced it has signed a Citizen Green Efixii (“Efixii”) Reseller & License Agreement (“Agreement”) with Transparent-C Ltd. (“Transparent-C”), a provider of regulatory and professional services to Israeli medical cannabis market […]

End of Year 2020 – Investors Update

Dear Friends, As I reflect on this turbulent past year, I am truly amazed how far we have come with your help since we set out on the journey of creating better outcomes for medical cannabis patients. As such, I would like to take this opportunity to thank all of our shareholders, partners, and other […]

GCAC Announces Commercial Launch of Medical Cannabis Efficacy App

Efixii platform connects cultivators to consumers while promoting product transparency.    The new app allows consumers to rate cannabis efficacy, earn rewards, and purchase reports.   Vancouver, British Columbia, Canada, December 15, 2020 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis platform, today announced the launch of Efixii, […]

GCAC Outlines Its Ethereum 2.0 Roadmap for Medical Cannabis

Vancouver, British Columbia, Canada, December 1, 2020 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading commercial licensor of proprietary blockchain Data and AI technologies to the medical cannabis industry, today outlined its Ethereum 2.0 rollup-centric roadmap, Eth2; continuing its focus on the benefits that Ethereum-truths bring to the Canadian medical […]

GCAC Enters into Definitive Agreement with Purity-IQ Biotechnology

Vancouver, British Columbia, Canada, November 10, 2020 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading commercial licensor of proprietary Data and AI technologies to the medical cannabis industry, today announced that it has signed a Definitive Agreement (“Agreement”) with Canadian company Purity-IQ Inc. (“Purity-IQ”) to commercially integrate the Purity-IQ Cannabis […]

GCAC Announces End-to-End SaaS Licensing for All Medical Cannabis Lifecycle Participants

 Vancouver, British Columbia, Canada, October 29, 2020 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading commercial licensor of proprietary Data and AI technologies to the medical cannabis industry, today announced the expansion of Citizen Green’s Software-as-a-Service (“SaaS”) commercial licensing to encompass the full medical cannabis product lifecycle. These new SaaS […]

Citizen Green Medical Cannabis Data-Acquisition Platform Goes Live with the Signing of a 3-Year SaaS Licensing Deal

Vancouver, British Columbia, Canada, October 14, 2020 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading commercial licensor of proprietary Data and AI technologies to the medical cannabis industry, today announced a definitive three-year software licensing deal with Bless Cultivation Ltd. (“Bless”), an Israeli based medical cannabis cultivator. This licensing agreement […]

GCAC Strengthens Its Medical Cannabis Efficacy Platform with Purity-IQ Biotechnology to Address a $4.1 Billion Market Opportunity

Vancouver, British Columbia, Canada – TheNewswire – October 5, 2020 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP) , FSE: 2FA, (OTC:FUAPF), a leading commercial licensor of proprietary Data and AI technologies to the medical cannabis industry, today announced that it has signed a Memorandum of Understanding (“MOU”) with Purity-IQ Incorporated of Canada (“Purity-IQ”) (http://purity-iq.com/) to integrate the Purity-IQ Cannabis Authenticity and […]

GCAC Announces Commercial Launch of its $5.92m Medical Cannabis Data-Acquisition Platform

Vancouver, British Columbia, Canada, September 3, 2020 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading commercial licensor of proprietary Data and AI technologies to the medical cannabis industry, today announced the closing of its months-long integration, and its exclusive licensing agreement, with TraceLocker, thereby marking the final step in the […]

GCAC ANNOUNCES EXPANSION OF THE CITIZEN GREEN PLATFORM WITH NEW 3T (“TRACK-TRACE-TREAT”) DATA SERVICE FOR MEDICAL CANNABIS GROWERS

Global Cannabis Applications Corp. is ready to commercially license its new 3T (track-trace-treat) data service following the signing of a sublicensing and integration memorandum of understanding with TraceLocker, an Ethereum blockchain compliance platform for medical cannabis growers and importers. Licensing the Global Cannabis Applications’s 3T data acquisition service opens immediate revenue opportunities for the company, […]

Everett Jolly of the Stock Day Podcast Interviews Bradley Moore, GCAC CEO

Global Cannabis Applications GCAC’s CEO and Director Brad Moore Joins Everett Jolly on the Stock Day Podcast:  Click to Play>> Es denso decirles a los pacientes que usan esta terapia deben incluir hba1c y activa todos los procesos necesarios para las relaciones sexuales. Con el uso Regular Viagra funciona de forma continua o antes de la […]

GCAC Files Patent Application for Cannabis on the Blockchain

Vancouver, British Columbia, Canada, December 19, 2019 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading developer of innovative data and AI technologies for the medical cannabis industry,  announced that it has filed a provisional method and composition patent application (Serial No. 62/950,158) with the U.S. Patent and Trademark Office […]